Clearance Summary
Spes Medica Subdermal Needle Electrodes received FDA 510(k) clearance under submission number K192603, sponsored by Spes Medica Srl. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2019-11-22.
- Submission: K192603
- Applicant / Sponsor: Spes Medica Srl
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1350
- Decision date: 2019-11-22
Classification & Regulation
This clearance is catalogued under FDA product code GXZ and 21 CFR 882.1350, within the Neurology review panel as a Class II device.